Martin Shkreli is a former hedge fund manager, entrepreneur, and convicted felon from Albania. He was the former CEO of Turing Pharmaceuticals, a pharmaceutical company. Martin Shkreli net worth is expect to reach around $70 million by 2022. Martin was found guilty of two counts of securities fraud in federal court in September 2015 after raising the price of the anti parasitic medicine Daraprim from $13.50 to $750 per pill. He is currently incarcerate in a low-security prison in Allenwood, Pennsylvania, serving a seven-year term. Continue reading to learn more about Martin Shkreli wife, financial worth, and other details.
Who is Martin Shkreli wife Christie Smythe?
Martin Shkreli was dating Christie Smythe, a former Bloomberg News reporter. Christie, the lady he was rumor to be dating, was the one who broke the news to the public about his detention in 2015. Martin claimed they were life partners, so Smythe decided to be with him. They broke up in October 2021, according to Smythe, and are now just friends. Martin Shkreli wife Christie Smythe is not with him.

Why is Martin Shkreli known as the “Pharma Bro”?
Martin Shkreli worked for Elea Capital, MSMB Capital Management, and MSMB Healthcare as a hedge fund manager. He’s also the co-founder and former CEO of the biotech company Retrophin, as well as the creator and former CEO of Turing Pharmaceuticals.
Read more: Who is Sirajuddin Haqqani wife? net worth, father, wanted
Shkreli, who was dubbed “Pharma Bro” by the media, was chastise when Turing got the production license for the Aids medicine Daraprim. In August 2015, he increased the prices by approximately 5,000 percent overnight. Shkreli was label “the most loathed man in the world” at the time after raising the price, and while price gouging is typical in the pharmaceutical industry in the United States, he become the poster boy for corporate excess.
Martin Shkreli net worth is estimated to be in the millions of dollars
Martin net worth is expect to be $0 as of May 2022, according to Celebrity Net Worth. Shkreli net worth peaked at roughly $70 million, but it has steadily declined since his conviction.

Martin was sentence to forfeit $5 million from his ETrade account and $2.36 million in other assets, including a Pablo Picasso painting and the only copy of the Wu-Tang Clan’s Once Upon a Time in Shaolin. On July 27, 2021, the US government report that the record had been sold to an unnamed buyer for an undisclosed sum.
“Shkreli has been held accountable and paid the price for misleading investors and stealing from them to enrich himself,” said Jacquelyn M. Kasulis, Acting United States Attorney for the Eastern District of New York. “His forfeiture payment is now complete with today’s sale of this one-of-a-kind CD.”
Read more: Who is politician Austin Davis wife Blayre Holmes? net worth, divorce
Shkreli had previously paid $2 million for the record at an auction in 2015. Wu-Tang Clan is a hip-hop group from the United States. Martin Shkreli was also sue for $100 million by Blue Cross Blue Shield of Minnesota in March 2021 for allegedly “scheming to dominate the market” on Daraprim.
Martin Shkreli was imprisoned for what reason?
According to the BBC, Shkreli was sentence to seven years in prison and order to pay a $75,000 fine and $7.3 million in forfeiture in 2018 for misleading investors.
He was found guilty of two charges of securities fraud and one count of securities fraud conspiracy.
The pharmaceutical executive defrauded investors in his hedge funds, MSMB Capital Management and MSMB Healthcare Management, by providing false information. He then stole from his drug company Retrophin to repay investors for more than $10 million.
How did Martin Shkreli get his early release?
Shkreli was imprison in a low-security federal prison in Allenwood, Pennsylvania, but was release on May 18, 2022.
“We can confirm Martin Shkreli transitioned on May 18, 2022, from the Federal Correctional Institution Allenwood Low to community confinement monitored by the Bureau of Prisons’ (BOP) New York Residential Re-entry Management Office,” according to a statement from the Federal Bureau of Prisons.
“I am glad to say Martin Shkreli has been release from Allenwood jail and sent to a BOP halfway house,” his lawyer, Benjamin Brafman, said. Shkreli was also release “after completing all programs that permit his sentence to be lower,” according to his lawyer.
Read more: How model Devon Aoki amassed her $30 Million net worth? Husband
According to The Guardian, he will be release from the halfway house on September 14th, 2022. Following his release from prison, the former hedge fund owner posted a photo of himself in a car on Facebook with the message, “Getting out of real prison is simpler than getting out of Twitter prison.”
Martin Shkreli wiki/bio- Parents, education, siblings, childhood
Shkreli was born in New York City on March 17, 1983. When his parents came to the United States from Albania and Croatia, they worked as janitors. He grew up in a working-class neighborhood in Sheepshead Bay, Brooklyn, with his two sisters.
While playing chess with a neighbor as a child, he developed an interest in stocks. He also bought his first equity shares in the technology business Compaq when he was 12 years old. When he was 15, he made an investment in Amazon.
Shkreli went to Hunter College High School, but it’s unclear whether or not he graduated. Martin graduated from City-As-School High School with a high school diploma.
What was his professional beginning?
Martin began working as an intern at Wall Street hedge fund Cramer, Berkowitz, and Company after graduating from high school when he was 16 years old. While at Regeneron Pharmaceuticals, he projected that the stock would plummet.
His prediction came true, drawing the Securities and Exchange Commission’s attention. He worked as a financial analyst at Intrepid Capital Management and UBS Wealth Management after four years as an associate.
Read more: How did Sean Kyle Swayze net worth staggering? Bio, relationship
Elea Capital Management, his first hedge fund, was found in 2006. He created MSMB Capital Management in 2009 and started shorting biotech stocks. He started Retrophin, a firm that discovers medications for rare disorders, after two years.
Recent Comments